Meta-Analysis of Circulating Cell-Free DNA’s Role in the Prognosis of Pancreatic Cancer

Meta-Analysis of Circulating Cell-Free DNA’s Role in the Prognosis of Pancreatic Cancer

Introduction: The analysis of cell-free DNA (cfDNA) for genetic abnormalities is a promising new approach for the diagnosis and prognosis of pancreatic cancer patients. Insights into the molecular characteristics of pancreatic cancer may provide valuable information, leading to its earlier detection...

Full description

Bibliographic Details
Main Authors:	Jelena Milin-Lazovic, Petar Madzarevic, Nina Rajovic, Vladimir Djordjevic, Nikola Milic, Sonja Pavlovic, Nevena Veljkovic, Natasa M. Milic, Dejan Radenkovic
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	cell-free DNA pancreatic ductal adenocarcinoma survival meta-analysis
Online Access:	https://www.mdpi.com/2072-6694/13/14/3378

Similar Items

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Aberrant downstream mechanisms following depletion of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma
by: Dawkins, Joshua Benjamin Newton
Published: (2017)

Significance of frailty in prognosis after surgery in patients with pancreatic ductal adenocarcinoma
by: Shinichiro Yamada, et al.
Published: (2021-03-01)

Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
by: Andrea N. Riner, et al.
Published: (2020-06-01)

Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01)

Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma
by: Haoran Li, et al.
Published: (2021-05-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
by: Takahiro Yokose, et al.
Published: (2020-06-01)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
by: Ren L, et al.
Published: (2018-01-01)

Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
by: Lili Wang, et al.
Published: (2017-05-01)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
by: Christelle d’Engremont, et al.
Published: (2021-05-01)

Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01)

Undifferentiated carcinoma of the pancreas with osteoclast-like giant cells reported in an asymptomatic patient: a rare case and literature review
by: Ramen Sakhi, et al.
Published: (2017-12-01)

A feasible CT feature to differentiate focal‐type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
by: Chaobin He, et al.
Published: (2019-10-01)

NEK7 Promotes Pancreatic Cancer Progression And Its Expression Is Correlated With Poor Prognosis
by: Zilong Yan, et al.
Published: (2021-07-01)

Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
by: Yalu Zhang, et al.
Published: (2021-06-01)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
by: Yuzhen Gao, et al.
Published: (2020-09-01)

Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
by: Joni Leppänen, et al.
Published: (2018-07-01)

Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
by: Benjamin M. MacCurtain, et al.
Published: (2021-06-01)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
by: Jedrzej J. Jaworski, et al.
Published: (2020-12-01)

Diagnosis of the pancreatic cancer
by: Przemysław Raczkiewicz, et al.
Published: (2021-09-01)

Dynamic serum alkaline phosphatase is an indicator of overall survival in pancreatic cancer
by: Yuanyuan Xiao, et al.
Published: (2019-08-01)

Long-term survival with repeat resection for lung oligometastasis from pancreatic ductal adenocarcinoma: a case report
by: Ryota Matsuki, et al.
Published: (2018-03-01)

Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)

Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
by: John C. Chang, et al.
Published: (2017-03-01)

Impact of tumor size on survival of patients with resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
by: Debang Li, et al.
Published: (2018-10-01)

A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics
by: Li, J., et al.
Published: (2022)

Protein Corona Fingerprints of Liposomes: New Opportunities for Targeted Drug Delivery and Early Detection in Pancreatic Cancer
by: Sara Palchetti, et al.
Published: (2019-01-01)

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
by: Daniela Massihnia, et al.
Published: (2017-01-01)

Unusual Masses of the Pancreas to Be Aware of
by: Muriel Genevay, et al.
Published: (2009-11-01)

Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal Adenocarcinoma
by: Hweixian Leong Penny, et al.
Published: (2021-06-01)

STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
by: Shanshan Hu, et al.
Published: (2020-09-01)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
by: Bathiya Ratnayake, et al.
Published: (2020-07-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging in Pancreatic Cancer is Associated with Tumor Hypoxia
by: Philipp Mayer, et al.
Published: (2021-12-01)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
by: Yousra Mohamed Abd-El-Halim, et al.
Published: (2021-09-01)

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
by: Hendrik Seeliger, et al.
Published: (2018-10-01)

High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma
by: Maria Cristina Curia, et al.
Published: (2019-05-01)

Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis
by: Nishikawa, Yoshihiro
Published: (2019)

The Landscape of Genetic Alterations Stratified Prognosis in Oriental Pancreatic Cancer Patients
by: Shiwei Guo, et al.
Published: (2021-07-01)